PCDHGB7 and breast carcinoma: Conversely, both cell lines attained additional chemoresistance to carboplatin when the PCDHGB7 gene was knocked down (Figures 2(b) and 2(d), P < 0.001), confirming that PCDHGB7 positively enhances the chemosensitivity of breast cancer cells to carboplatin.